Juno cancer study halted after patient deaths, shares fall 30 pct

July 7 (Reuters) - A Juno Therapeutics Inc trial of

its experimental CAR-T therapy, known as JCAR015, was put on

hold by U.S. regulators after the deaths last week of two

leukemia patients enrolled...

Read more